Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Mindy Simpson

Pediatrics Chicago, IL Medical Doctor

NPI 1164477246 CMS profile 188620

1653 W Congress Pkwy, 1591 Jelke, Chicago, IL 60612

Open in the dashboard

General payments

$318,338

310 records reported · program years 2019–2025

Research payments

$100

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$705,952 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Mindy Simpson of Chicago, IL is reported in the CMS Open Payments database as having received $318,338 across 310 general payments and $100 in research payments paid to them. Separately, studies naming them as principal investigator received $705,952 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Pediatrics profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $76,438 54
2024 General $48,551 38
2023 General $52,262 40
2022 General $29,675 33
2021 General $23,159 32
2020 General $35,068 21
2019 General $53,185 92
2019 Research $100 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Mindy Simpson
  • Pediatrics median
  • Middle half of Pediatrics
  • National median

In program year 2025, general payments to Mindy Simpson were reported at $76,438. Among 22,296 Pediatrics profiles paid that year, the median was $97 and the middle half received between $37 and $210.

Show as a table
Year Mindy Simpson Pediatrics median Middle half National median
2019 $53,185 $86 $31–$183 $163
2020 $35,068 $49 $22–$110 $114
2021 $23,159 $68 $27–$158 $132
2022 $29,675 $77 $30–$173 $149
2023 $52,262 $88 $33–$190 $160
2024 $48,551 $94 $34–$206 $164
2025 $76,438 $97 $37–$210 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. CSL Behring $92,190 80 payments
  2. Novo Nordisk Inc $82,867 66 payments
  3. Genzyme Corporation $71,592 34 payments
  4. Pfizer Inc. $21,594 18 payments
  5. Bayer HealthCare Pharmaceuticals Inc. $14,802 26 payments
  6. Genentech USA, Inc. $14,253 21 payments
  7. Takeda Pharmaceuticals U.S.A., Inc. $9,746 9 payments
  8. Octapharma USA, Inc. $4,568 15 payments
  9. Medexus Pharma, Inc. $2,600 1 payment
  10. BioMarin Pharmaceutical Inc. $2,003 3 payments
  11. Other $2,124 37 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $144,484 27 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $97,730 42 payments
  3. Travel and Lodging $48,245 89 payments
  4. Honoraria $20,730 6 payments
  5. Food and Beverage $7,110 144 payments
  6. Grant $25 1 payment
  7. Education $15 1 payment
Products named General payments · program years 2019–2025
  1. Idelvion $66,608 59 payments
  2. Afstyla $32,040 25 payments
  3. HEMLIBRA $14,237 20 payments
  4. QFITLIA $11,392 7 payments
  5. NovoSeven $9,973 9 payments
  6. NovoSeven RT $9,817 13 payments
  7. HEMGENIX $8,883 10 payments
  8. HYMPAVZI $6,195 3 payments
  9. REBINYN $4,986 4 payments
  10. ALPROLIX $4,572 3 payments
  11. Other $32,601 88 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Genzyme Corporation $100 1 payment

Records

311 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pediatrics in Illinois

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record